Recall
FDAHealthDecember 3, 2025

Medtronic Neuromodulation — A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT9

⚠️ Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.

Is this relevant to me?

Geography
Nationwide
Source agency
FDA
Category
Health
Published
December 3, 2025

Worldwide - US Nationwide distribution.

What's affected?

Product
A71200 Vanta" Clinician Programmer Application (CP App) version 2.0.2465 and 2.0.2683, Product number A71200. Software is deployed and operated on Samsung tablets (CFN CT900).
Lot code
version 2.0.2465 and 2.0.2683 UDI-DI (GTIN) 00763000520083 Affected product is the software. Implanted Vanta Neurostimulator devices are not affected.

Additional details

version 2.0.2465 and 2.0.2683 UDI-DI (GTIN) 00763000520083 Affected product is the software. Implanted Vanta Neurostimulator devices are not affected.

What should I do?

Recommended action

Class II recall. Voluntary: Firm initiated Quantity affected: 7123.

View original FDA notice →

Get Health recall alerts

Delivered to your inbox. Free. No account required.